Item Type | Name |
Academic Article
|
Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.
|
Academic Article
|
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
|
Academic Article
|
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy.
|
Academic Article
|
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells.
|
Academic Article
|
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.
|
Academic Article
|
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
|
Academic Article
|
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.
|
Academic Article
|
An inducible caspase 9 safety switch for T-cell therapy.
|
Academic Article
|
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.
|
Academic Article
|
Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy.
|
Academic Article
|
Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.
|
Academic Article
|
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.
|
Academic Article
|
Vaccine therapies for pediatric malignancies.
|
Academic Article
|
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.
|
Academic Article
|
American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.
|
Academic Article
|
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.
|
Academic Article
|
Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications.
|
Academic Article
|
CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells.
|
Academic Article
|
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma.
|
Academic Article
|
Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.
|
Academic Article
|
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
|
Academic Article
|
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
|
Academic Article
|
Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells.
|
Academic Article
|
Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells.
|
Academic Article
|
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.
|
Academic Article
|
Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.
|
Academic Article
|
[Gene therapy of childhood cancers: current status and perspectives].
|
Academic Article
|
The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
|
Academic Article
|
Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment.
|
Academic Article
|
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor.
|
Academic Article
|
A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma.
|
Academic Article
|
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
|
Academic Article
|
Chimeric T-cell receptors for the targeting of cancer cells.
|
Academic Article
|
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.
|
Academic Article
|
Primitive adult hematopoietic stem cells can function as osteoblast precursors.
|
Academic Article
|
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
|
Academic Article
|
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.
|
Academic Article
|
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.
|
Academic Article
|
Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.
|
Academic Article
|
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells.
|
Academic Article
|
Overview of gene therapy clinical progress including cancer treatment with gene-modified T cells.
|
Academic Article
|
Targeted delivery of adenoviral vectors by cytotoxic T cells.
|
Academic Article
|
Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential.
|
Academic Article
|
Cellular immunotherapy of cancer.
|
Academic Article
|
Defining the risks of mesenchymal stromal cell therapy.
|
Academic Article
|
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.
|
Academic Article
|
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors.
|
Academic Article
|
Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.
|
Academic Article
|
Inducible apoptosis as a safety switch for adoptive cell therapy.
|
Academic Article
|
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells.
|
Academic Article
|
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.
|
Academic Article
|
Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
|
Academic Article
|
Hypoxic adipocytes pattern early heterotopic bone formation.
|
Academic Article
|
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
|
Academic Article
|
Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin.
|
Academic Article
|
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
|
Academic Article
|
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
|
Academic Article
|
T-cell therapy after hematopoietic stem cell transplantation.
|
Academic Article
|
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
|
Academic Article
|
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
|
Academic Article
|
Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
|
Academic Article
|
The clone ranger?
|
Academic Article
|
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
|
Academic Article
|
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
|
Academic Article
|
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).
|
Academic Article
|
Immunotherapy of human cancers using gene modified T lymphocytes.
|
Academic Article
|
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
|
Academic Article
|
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.
|
Academic Article
|
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.
|
Academic Article
|
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.
|
Academic Article
|
T cell receptors and cancer: gain gives pain.
|
Academic Article
|
IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.
|
Academic Article
|
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
|
Academic Article
|
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.
|
Academic Article
|
Genetic modification of T cells.
|
Academic Article
|
Cell-specific transmembrane injection of molecular cargo with gold nanoparticle-generated transient plasmonic nanobubbles.
|
Academic Article
|
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
|
Academic Article
|
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
|
Academic Article
|
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.
|
Academic Article
|
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.
|
Academic Article
|
Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection.
|
Academic Article
|
Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma.
|
Academic Article
|
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.
|
Academic Article
|
Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.
|
Academic Article
|
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.
|
Academic Article
|
Prompt versus preemptive intervention for EBV lymphoproliferative disease.
|
Academic Article
|
Antigen-induced regulatory T cells.
|
Academic Article
|
Genetic modification of T lymphocytes for adoptive immunotherapy.
|
Academic Article
|
Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.
|
Academic Article
|
E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
|
Academic Article
|
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
|
Academic Article
|
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
|
Academic Article
|
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.
|
Academic Article
|
The continuing contribution of gene marking to cell and gene therapy.
|
Academic Article
|
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
|
Academic Article
|
Developing T-cell therapies for cancer in an academic setting.
|
Academic Article
|
Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.
|
Academic Article
|
Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.
|
Academic Article
|
Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?".
|
Academic Article
|
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
|
Academic Article
|
Adoptive T cell therapy of cancer.
|
Academic Article
|
An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies.
|
Academic Article
|
Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.
|
Academic Article
|
Stemming our irrational exuberance.
|
Academic Article
|
Cellular therapy for cancer: let there be light.
|
Academic Article
|
Will T-cell therapy for cancer ever be a standard of care?
|
Concept
|
Jurkat Cells
|
Concept
|
Lymphoma, T-Cell
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Lymphocytes
|
Concept
|
Vero Cells
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
COS Cells
|
Concept
|
Dendritic Cells
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
Concept
|
Clone Cells
|
Concept
|
K562 Cells
|
Concept
|
Th1 Cells
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
Concept
|
Reed-Sternberg Cells
|
Concept
|
Blood Cells
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
Induced Pluripotent Stem Cells
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
Antigen-Presenting Cells
|
Concept
|
Stromal Cells
|
Concept
|
Th2 Cells
|
Concept
|
Embryonic Stem Cells
|
Concept
|
B-Lymphocytes
|
Concept
|
Leukemia-Lymphoma, Adult T-Cell
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Epitopes, T-Lymphocyte
|
Concept
|
Adult Stem Cells
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Bone Marrow Cells
|
Concept
|
Hep G2 Cells
|
Concept
|
Pluripotent Stem Cells
|
Concept
|
Myeloid Cells
|
Concept
|
Killer Cells, Natural
|
Concept
|
Cells, Cultured
|
Concept
|
Stem Cells
|
Concept
|
T-Lymphocytes
|
Academic Article
|
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
|
Academic Article
|
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
|
Academic Article
|
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
|
Academic Article
|
Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition.
|
Academic Article
|
CAR T cells for acute myeloid leukemia: the LeY of the land.
|
Academic Article
|
Design and development of therapies using chimeric antigen receptor-expressing T cells.
|
Academic Article
|
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
|
Academic Article
|
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
|
Academic Article
|
Reversal of tumor immune inhibition using a chimeric cytokine receptor.
|
Academic Article
|
Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.
|
Academic Article
|
Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.
|
Academic Article
|
Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.
|
Academic Article
|
Antiviral T-cell therapy.
|
Academic Article
|
Engineered T cells for cancer treatment.
|
Academic Article
|
Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.
|
Academic Article
|
Gene-modified cells for stem cell transplantation and cancer therapy.
|
Academic Article
|
Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.
|
Academic Article
|
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
|
Academic Article
|
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.
|
Academic Article
|
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.
|
Academic Article
|
Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch.
|
Academic Article
|
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation.
|
Academic Article
|
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.
|
Academic Article
|
An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells.
|
Academic Article
|
iCaspase 9 Suicide Gene System.
|
Academic Article
|
Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
|
Academic Article
|
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.
|
Academic Article
|
CAR-T Cell Therapy for Lymphoma.
|
Academic Article
|
Clinical responses with T lymphocytes targeting malignancy-associated ? light chains.
|
Academic Article
|
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.
|
Academic Article
|
Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation.
|
Academic Article
|
3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus.
|
Academic Article
|
GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.
|
Academic Article
|
Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch.
|
Academic Article
|
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.
|
Academic Article
|
Fine-tuning the CAR spacer improves T-cell potency.
|
Academic Article
|
Improving the safety of T-Cell therapies using an inducible caspase-9 gene.
|
Academic Article
|
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors.
|
Academic Article
|
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
|
Academic Article
|
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
|
Academic Article
|
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
|
Academic Article
|
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.
|
Academic Article
|
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
|
Academic Article
|
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.
|
Academic Article
|
Next Steps in the CAR Journey of a Thousand Miles.
|
Academic Article
|
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.
|
Academic Article
|
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.
|
Academic Article
|
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.
|
Academic Article
|
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals.
|
Academic Article
|
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
|
Academic Article
|
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.
|
Academic Article
|
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation.
|
Academic Article
|
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment.
|
Academic Article
|
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia.
|
Academic Article
|
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.
|
Grant
|
ACTIVITY OF LYMPHOTACTIN IN CHILDHOOD MALIGNANCY
|
Grant
|
Combined CTL and CD45 antibody for nasopharyngeal carci*
|
Grant
|
CD45 ANTIBODY EFFECT ON NORMAL AND MALIGNANT HEMOPOIESIS
|
Grant
|
Haploidentical Allogeneic Transplantation
|
Grant
|
Improving the safety and efficacy of cell therapies
|
Grant
|
TREATMENT OF NEUROBLASTOMA WITH IL2 TRANSDUCED TUMOR
|
Grant
|
THERAPEUTIC EFFECTS OF CD40L IN ACUTE LYMPHOBLASTIC LEUK
|
Academic Article
|
In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
|
Academic Article
|
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
|
Academic Article
|
Chimeric Antigen Receptors for T-Cell Malignancies.
|
Concept
|
A549 Cells
|
Concept
|
HEK293 Cells
|
Concept
|
Human Umbilical Vein Endothelial Cells
|
Academic Article
|
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
|
Academic Article
|
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.
|
Academic Article
|
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells.
|
Academic Article
|
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.
|
Academic Article
|
Engineered off-the-shelf therapeutic T cells resist host immune rejection.
|
Academic Article
|
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma.
|
Academic Article
|
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
|
Academic Article
|
Modulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia.
|
Academic Article
|
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8a?-engineered human CD4+ T cells.
|
Academic Article
|
Transgenic CD8a? co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells.
|
Academic Article
|
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
|
Academic Article
|
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.
|
Academic Article
|
Taking T-Cell Oncotherapy Off-the-Shelf.
|
Academic Article
|
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.
|
Academic Article
|
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors.
|
Academic Article
|
Reversal of exhaustion in engineered T cells.
|
Academic Article
|
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas.
|
Academic Article
|
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.
|
Academic Article
|
Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy.
|
Academic Article
|
Targeting glycans for CAR therapy: The advent of sweet CARs.
|
Academic Article
|
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies.
|
Academic Article
|
Engineering T cells to suppress acute GVHD and?leukemia relapse after allogeneic hematopoietic stem cell transplantation.
|
Academic Article
|
Emerging Challenges to Cellular Therapy of Cancer.
|
Academic Article
|
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma.
|
Academic Article
|
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
|
Academic Article
|
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy.
|
Academic Article
|
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
|
Academic Article
|
Human platelet lysate enhances in vivo activity of CAR-Vd2 T cells by reducing cellular senescence and apoptosis.
|